- Trials with a EudraCT protocol (39,275)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
39,275 result(s) found for: $1.
Displaying page 477 of 1,964.
EudraCT Number: 2016-000307-93 | Sponsor Protocol Number: CICL670F2105 | Start Date*: 2016-03-09 |
Sponsor Name:Novartis Pharmaceuticals Corporation | ||
Full Title: A randomized, open label, single center, phase I, two way, cross-over study to evaluate the pharmacokinetic comparability of deferasirox new granule formulation with the reference dispersible formu... | ||
Medical condition: Healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2020-000878-15 | Sponsor Protocol Number: NL72398.041.19 | Start Date*: 2020-04-15 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: Sentinel node Navigation surgery in early esophageal Adenocarcinoma Patients with lymph node involvement: SNAP-IV study | ||
Medical condition: Esophageal adenocarcinoma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001884-38 | Sponsor Protocol Number: I5Q-MC-CGAJ | Start Date*: 2015-12-07 |
Sponsor Name:Eli Lilly and Company | ||
Full Title: A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 in Patients with Migraine. | ||
Medical condition: Episodic or chronic migraine headache | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) BE (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000690-22 | Sponsor Protocol Number: CP4055-201 | Start Date*: 2005-08-16 |
Sponsor Name:Clavis Pharma as | ||
Full Title: A phase II Clinical Study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapy | ||
Medical condition: A phase II clinical study of CP-4055 in patients with metastatic melanoma not previous treated with chemotherapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001195-13 | Sponsor Protocol Number: 21651 | Start Date*: 2005-08-18 |
Sponsor Name:University of Leeds | ||
Full Title: The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project: An open label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for prison ... | ||
Medical condition: Opiate addiction (detoxification from illicit opiates) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001045-34 | Sponsor Protocol Number: ASL604LIOM02 Studio CPTTS | Start Date*: 2005-04-05 | |||||||||||
Sponsor Name:AZIENDA USL 6 LIVORNO ZONA LIVORNESE | |||||||||||||
Full Title: Metronomic chemiotherapic treatment WITH IRINOTECAN Cpt-11 IN PATIENTS WITH metastatic colon-rectal cancer PHARMACODYNAMIC And PHARMACOKINETIC evaluation. | |||||||||||||
Medical condition: Colonrectal metatstatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-005174-23 | Sponsor Protocol Number: CAVA2Dec04 | Start Date*: 2005-04-11 |
Sponsor Name:NHS Grampian | ||
Full Title: Is smooth muscle mitogenesis down regulated by platelet inactivation with combination antiplatelet therapy after angioplasty for claudication? | ||
Medical condition: Intermittent claudication = stenosis of superficial femoral artery requiring percutaneous angioplasty | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001569-33 | Sponsor Protocol Number: LLC-R-FCM-1 | Start Date*: 2005-09-23 |
Sponsor Name:Dept. Hematology, Hospital Clinic | ||
Full Title: First line treatment with rituximab plus fludarabine, cyclophosphamide, mitoxantrone (R-FCM) and maintenance therapy with rituximab in patients diagnosed with chronic lymphocytic leukemia. Tratamie... | ||
Medical condition: Patients diagnosed with chronic lymphocytic leukemia (CLL) according to the WHO guidelines, within 18 and 71 years and not previously treated | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001225-16 | Sponsor Protocol Number: 3001077 | Start Date*: 2004-10-28 |
Sponsor Name:Orion Pharma | ||
Full Title: Survival of patients with acute heart failure in need of intravenous inotropic support; a multicentre parallel- group, randomised, double- blind, double- dummy study of levosimendan versus dobutami... | ||
Medical condition: Acutely decompensated heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-006041-16 | Sponsor Protocol Number: NK-104-310 | Start Date*: 2006-06-30 | |||||||||||
Sponsor Name:Kowa Research Europe Ltd. | |||||||||||||
Full Title: DOUBLE-BLIND FOLLOW-ON STUDY OF PITAVASTATIN (4 MG) VERSUS ATORVASTATIN (20 MG AND 40 MG), WITH A SINGLE BLIND EXTENSION OF TREATMENT IN PATIENTS WITH TYPE II DIABETES MELLITUS AND COMBINED DYSLIPI... | |||||||||||||
Medical condition: Combined Dyslipidemia and Type II Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002875-34 | Sponsor Protocol Number: CL-070-II-02 | Start Date*: Information not available in EudraCT |
Sponsor Name:IDEA AG | ||
Full Title: Safety and efficacy of IDEA-070 for the treatment of pain and inflammation induced by photodynamic therapy of actinic keratosis | ||
Medical condition: Patients suffering from actinic keratosis to be treated with PDT | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001184-29 | Sponsor Protocol Number: IMA-GER-0601 | Start Date*: 2006-07-06 |
Sponsor Name:Spirig Pharma AG | ||
Full Title: A controlled, randomized, evaluator-blinded study for the assessment of efficacy and safety of Imazol® Paste and Multilind® Heilsalbe in infants with diaper dermatitis | ||
Medical condition: Diaper dermatitis (diaper rash) | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005848-87 | Sponsor Protocol Number: 250708BS (CRx-191-001) | Start Date*: 2007-10-08 |
Sponsor Name:CombinatoRx, Inc. | ||
Full Title: A single-center, randomized, double-blind, vehicle-controlled study to assess the activity of CRx-191 in reducing the psoriatic infiltrate band thickness in plaque psoriasis. | ||
Medical condition: Plaque psoriasis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003015-23 | Sponsor Protocol Number: RD.03.SPR.29044 | Start Date*: 2005-01-21 |
Sponsor Name:Laboratorios Galderma S.A. | ||
Full Title: Estudio de la eficacia y seguridad de la Terapia Fotodinámica con Metil Aminolevulinato en crema (Metvix®) en pacientes de alto riesgo con Carcinoma Basocelular Superficial (CBCs). | ||
Medical condition: Carcinoma Basocelular Superficial (CBCs) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003975-35 | Sponsor Protocol Number: 750201.01.014 | Start Date*: 2005-05-18 |
Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | ||
Full Title: Multi-center, double-blind, placebo-controlled, randomized phase III study to prove the efficacy, safety and tolerability of Lavender oil WS 1265 (Lavandula angustifolia) in patients with restlessn... | ||
Medical condition: restlessness and sleep disturbances MedDRA Code for RESTLESSNESS: 10038743 MedDRA Code für SLEEP DISTURBANCES: 10040997 | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-005223-18 | Sponsor Protocol Number: NRA6280030 | Start Date*: 2005-05-12 |
Sponsor Name:Childrens´ Hospital Erlangen | ||
Full Title: Evaluation of growth response in short children suffering from a disease with growth retardation and treated with Somatropin: A prospective, longitudinal non-randomised, open, phase II study | ||
Medical condition: Genotropin®) is approved for treatment of short statured children in specific indications. A benefit can also be achieved in other pathological conditions that lead to growth retardation. Because ... | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001134-32 | Sponsor Protocol Number: 19.4.209B | Start Date*: 2005-08-18 |
Sponsor Name:NV Organon | ||
Full Title: A multi-center, randomized, open-label, prospective bridging, parallel dosefinding trial comparing efficacy and safety of 5 doses of Org 25969 administered at 1-2 PTC after rocuronium or vecuronium... | ||
Medical condition: Not applicable | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001502-11 | Sponsor Protocol Number: ML18434 | Start Date*: 2005-07-18 |
Sponsor Name:Roche Austria GmbH | ||
Full Title: “CHAIROS” – Early brief intensification by chemoimmunotherapy with FCR followed by FR and Rituximab maintenance in chemonaive patients with B-CLL – A phase II study | ||
Medical condition: Chronic lymphocytic leukemia (CLL) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004201-29 | Sponsor Protocol Number: CM-05-08/HU | Start Date*: 2006-06-01 |
Sponsor Name:Alcon Hungarian ltd | ||
Full Title: THE EFFICACY AND SAFETY OF TIMOLOL MALEATE 0.5% COMPARED TO BRINZOLAMIDE 1% EACH GIVEN TWICE DAILY WHEN ADDED TO TRAVOPROST 0.004% GIVEN EACH EVENING IN PRIMARY OPEN-ANGLE GLAUCOMA OR OCULAR HYPERT... | ||
Medical condition: Increased intraocular pressure and glaucoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-003472-19 | Sponsor Protocol Number: version 4.0, 31 May 2007 | Start Date*: 2007-09-13 |
Sponsor Name:Royal Free Hampstead NHS Trust | ||
Full Title: Determining a viral load threshold for pre-emptive therapy for cytomegalovirus infection in transplant patients using real time PCR monitoring. | ||
Medical condition: Transplant recipients with CMV infection. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
